Rufibach, L.; Berger, K.; Chakravorty, S.; Emmons, S.; Long, L.; Gibson, G.; Hegde, M.
Utilization of Targeted RNA-Seq for the Resolution of Variant Pathogenicity and Enhancement of Diagnostic Yield in Dysferlinopathy. J. Pers. Med. 2023, 13, 520.
https://doi.org/10.3390/jpm13030520
AMA Style
Rufibach L, Berger K, Chakravorty S, Emmons S, Long L, Gibson G, Hegde M.
Utilization of Targeted RNA-Seq for the Resolution of Variant Pathogenicity and Enhancement of Diagnostic Yield in Dysferlinopathy. Journal of Personalized Medicine. 2023; 13(3):520.
https://doi.org/10.3390/jpm13030520
Chicago/Turabian Style
Rufibach, Laura, Kiera Berger, Samya Chakravorty, Sarah Emmons, Laurie Long, Greg Gibson, and Madhuri Hegde.
2023. "Utilization of Targeted RNA-Seq for the Resolution of Variant Pathogenicity and Enhancement of Diagnostic Yield in Dysferlinopathy" Journal of Personalized Medicine 13, no. 3: 520.
https://doi.org/10.3390/jpm13030520
APA Style
Rufibach, L., Berger, K., Chakravorty, S., Emmons, S., Long, L., Gibson, G., & Hegde, M.
(2023). Utilization of Targeted RNA-Seq for the Resolution of Variant Pathogenicity and Enhancement of Diagnostic Yield in Dysferlinopathy. Journal of Personalized Medicine, 13(3), 520.
https://doi.org/10.3390/jpm13030520